Mayer Brezis on finasteride and drug regulation
A professor of medicine on why he thinks the regulators' response to finasteride took 20 years, and a culture he calls deny and defend.
This is coverage by another outlet. We link to it because it reports on PFS, PSSD or PAS — the reporting and any views in it are the publisher's, not ours.
Mayer Brezis believes the evidence that finasteride can cause psychiatric harm now meets the criteria for cause and effect. In this interview he talks about his 2025 study of finasteride.
He is a professor of medicine and public health at Hadassah-Hebrew University in Jerusalem. If you have taken finasteride, he offers one view of why its risks took so long to be recognised.
What did his study conclude?
A 2025 study of finasteride
Brezis says the study concluded that finasteride can cause depression and suicidality. He says it traces the long delay in recognising this partly to the manufacturer not carrying out and publishing simple drug-safety studies, and to regulators not asking for them or doing them.
What Brezis argues
- Why he believes the evidence linking finasteride to psychiatric harm now meets the criteria for cause and effect.
- How, in his view, a 20-year delay in the regulators’ response shows failures across the whole system.
- A culture he calls “deny and defend”, which he says stops modern medicine from correcting itself.
- Why he sees putting patient safety above profit as a moral duty.
Thank you to Mayer Brezis for this interview. It was recorded by Moral Medicine, who have filmed more than ninety of these conversations.
If you appear in this interview and would rather this page was not here, write to contact@sidefxhub.com. We will take the page down within 48 hours, and you do not have to tell us why.
660+ people have joined the registry.
Join them, then report your side effects.
Free. Sign up takes 2 minutes.